Welcome to our dedicated page for Pediatrix Medical Group news (Ticker: MD), a resource for investors and traders seeking the latest updates and insights on Pediatrix Medical Group stock.
Pediatrix Medical Group, Inc. provides physician services for women, babies and children across hospital settings and office-based practices. Its recurring updates center on obstetrics, maternal-fetal medicine, neonatology, neonatal intensive care unit activity and other pediatric subspecialties, with revenue concentrated in neonatology and pediatric subspecialty care.
Company news also covers quarterly operating results, same-unit revenue trends, reimbursement and payor-mix factors, patient acuity, hospital contract administrative fees, practice acquisitions and dispositions, service expansions, clinical quality initiatives and neonatology education through NEO: The Conference for Neonatology.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Pediatrix Medical Group, Inc. (NYSE: MD) will hold an investor conference call and webcast on May 2, 2023, at 9:00 a.m. ET, to discuss operational results for the quarter ending March 31, 2023. A detailed press release will be available on the same day before the markets open. Pediatrix is recognized as a leading provider of physician services in the U.S., focusing on maternity, neonatal, and pediatric care. The organization operates through more than 5,000 affiliated clinicians across 37 states. It emphasizes high-quality care backed by significant investments in research and safety initiatives.
Pediatrix Medical Group (NYSE: MD) has elected James D. Swift, M.D., as a director effective March 8, 2023, following his recent appointment as CEO. This election fills a seat previously held by co-founder Roger J. Medel, M.D., who is recognized for his extensive contributions to the company. Pediatrix, established in 1979, is a leading provider of physician services in the U.S., focusing on maternal-fetal medicine, neonatology, and pediatric care through over 5,000 affiliated clinicians. The company emphasizes coordinated, compassionate care supported by quality improvement and safety initiatives.